| abstract |
The invention relates to the use of thiazolo- [2,3-a] isoindol derivatives to produce anti-viral drugs and to new thiazolo- [2,3-a] isoindol derivatives, and in particular the use of derivatives having the general formula (I) for producing therapeutic drugs for viral or retroviral infections. In formula (I), X can denote an oxygen or sulfur atom, the imino = NH group or an N-C1-C5 alkylimino group; n is 0, 1 or 2; R denotes a hydrogen atom, an aliphatic residue or an optionally substituted carbocyclic or heterocyclic ring; R1 to R6 have the meaning given in the description. The invention also relates to their tautomers, enantiomers, diastereomers and physiologically admissible salts, as well as to new thiazolo [2,3-a] isoindols having the formula (I), in which R denotes a monocyclic, bicyclic or tricyclic heterocyclic ring. |